Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Catalyst Pharmaceutical Partners Inc buy Cantor Fitzgerald

Start price
€22.79
06.06.25 / 50%
Target price
-
06.06.26
Performance (%)
-20.25%
Price
€18.18
21:41
Summary
This prediction is currently active. The price of Catalyst Pharmaceutical Partners Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.25%. This prediction currently runs until 06.06.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Catalyst Pharmaceutical Partners Inc -2.097% -2.097%
iShares Core DAX® -0.446% 2.321%
iShares Nasdaq 100 -0.671% 3.178%
iShares Nikkei 225® -1.289% 4.197%
iShares S&P 500 -0.662% 2.125%

Comments by Cantor_Fitzgerald for this prediction

In the thread Catalyst Pharmaceutical Partners Inc diskutieren

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Ratings data for CPRX provided by MarketBeat

Stopped prediction by Cantor_Fitzgerald for Catalyst Pharmaceutical Partners Inc

buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€14.55
22.03.24
€31.46
22.03.25
64.12%
23.03.25

buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€16.00
01.03.24
€31.37
01.03.25
39.63%
02.03.25